Improving breast cancer screening and risk reduction through personalized approaches
Core D: Patient Centered Outcomes and Risk Communication
This study is all about making breast cancer screening better for you by understanding how your feelings and experiences can help shape new ways to encourage screenings, so you can make informed health choices that work for you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11159095 on NIH RePORTER |
What this research studies
This research focuses on enhancing breast cancer screening and risk reduction by personalizing approaches based on patient-centered outcomes. It aims to understand how perceptions, behaviors, and psychosocial factors influence patients' willingness to adopt new screening methods. By collecting data on patient experiences and outcomes, the project seeks to improve education and adherence to screening guidelines, ultimately leading to better health decisions. The research will also evaluate the cost-effectiveness of these personalized interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research include women at high risk for breast cancer who are considering or currently undergoing screening.
Not a fit: Patients who are not at risk for breast cancer or those who have already opted out of screening may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized breast cancer screening strategies that improve patient outcomes.
How similar studies have performed: Previous research has shown that personalized approaches in healthcare can lead to improved patient engagement and outcomes, suggesting potential success for this initiative.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Naeim, Arash — University of California, San Francisco
- Study coordinator: Naeim, Arash
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.